miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
about
NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer.Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.Tumor angiogenesis revisited: Regulators and clinical implications.Breast cancer stem cells-from origins to targeted therapy.Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression.Inhibition of TDP43-Mediated SNHG12-miR-195-SOX5 Feedback Loop Impeded Malignant Biological Behaviors of Glioma Cells.Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.Functional miRNAs in breast cancer drug resistance.Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia.Antitumor effects and mechanisms of olaparib in combination with carboplatin and BKM120 on human triple‑negative breast cancer cellsA role for FGF2 in visceral adiposity-associated mammary epithelial transformationmiRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
P2860
Q33709996-4F8E45E9-AAA6-497C-9079-3058A3D2C0E5Q33858033-C9A81CEF-D551-48C3-83D4-DE80DF76D5BFQ36188321-1A87742A-A397-455D-832A-C0B4F1597936Q39393740-74700A23-4633-45FB-8D83-D8561205C628Q47138666-C00D2C49-5ECD-4FF6-902C-BEBF20DBCBBDQ47649420-BB718674-DBE8-48EB-AB46-522F99BD678CQ47927636-5BFD9CF3-6BDB-400D-872E-F9F7393AD43EQ50192112-87E42FD8-00D9-4A33-AF40-E38E97E25147Q52561885-3D38DC7E-A36B-4A04-9091-4DB1070C58E1Q54090230-62A80E6C-9786-4C1B-B2D8-8B745EF07CD5Q55000578-15C34440-4430-49C9-A940-B6428A86F92EQ55434312-817D0DE0-F9EF-4596-A64E-790CD01D6F1BQ57072237-F04BD48E-2BA2-40C6-B190-1E21E040CCC5Q58156984-2B61EF69-81F9-4C95-9E2D-5F9EA24DBB3CQ58702679-D239C345-D111-4E3A-B0E1-6BBEDEA44BC1
P2860
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miRNA-205 targets VEGFA and FG ...... therapeutics in breast cancer.
@en
miRNA-205 targets VEGFA and FG ...... therapeutics in breast cancer.
@nl
type
label
miRNA-205 targets VEGFA and FG ...... therapeutics in breast cancer.
@en
miRNA-205 targets VEGFA and FG ...... therapeutics in breast cancer.
@nl
prefLabel
miRNA-205 targets VEGFA and FG ...... therapeutics in breast cancer.
@en
miRNA-205 targets VEGFA and FG ...... therapeutics in breast cancer.
@nl
P2093
P2860
P356
P1476
miRNA-205 targets VEGFA and FG ...... therapeutics in breast cancer.
@en
P2093
P2860
P356
10.1038/CDDIS.2016.194
P577
2016-06-30T00:00:00Z